{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:30Z","timestamp":1786119630750,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.1097\/qai.0b013e3181eb5ff5","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T07:14:50Z","timestamp":1284448490000},"page":"473-482","source":"Crossref","is-referenced-by-count":51,"title":["Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188"],"prefix":"10.1097","volume":"55","author":[{"given":"Mary A","family":"Vogler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Kamemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Gun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Aweeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin L","family":"Klingman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2307\/2673717","article-title":"Fertility desires and intentions of HIV-positive men and women.","volume":"33","author":"Chen","year":"2001","journal-title":"Fam Plann Perspect"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.contraception.2006.12.012","article-title":"Contraception and fertility plans in a cohort of HIV-positive women in care.","volume":"75","author":"Stanwood","year":"2007","journal-title":"Contraception"},{"key":"R6-9-20210131","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QAI.0b013e3181bc4869","article-title":"Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African Women.","volume":"53","author":"Reid","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-9-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jwh.2006.0204","article-title":"Contraceptive use among U.S. women with HIV.","volume":"16","author":"Massad","year":"2007","journal-title":"J Womens Health"},{"key":"R10-9-20210131","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive.","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"R11-9-20210131","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0010-7824(01)00273-6","article-title":"Multiple-dose pharmacokinetics of a contraceptive patch in healthy female subjects.","volume":"64","author":"Abrams","year":"2001","journal-title":"Contraception"},{"key":"R13-9-20210131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/09540120050042891","article-title":"Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instrument.","volume":"12","author":"Chesney","year":"2000","journal-title":"AIDS CARE"},{"key":"R15-9-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl estradiol in healthy female volunteers.","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/13625180701829952","article-title":"Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.","volume":"13","author":"El-Ibiary","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R17-9-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 mcg of ethinyl estradiol.","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"R18-9-20210131","first-page":"175","article-title":"Venous thromboembolism, myocardial infarction and stroke among transdermal contraceptive users. Obstet Gynecol. 2007; 109:339-346. Erratum in: Obstet Gynecol. 2008;111:1449.","volume":"114","author":"Cole","year":"2009","journal-title":"Comment in: Obstet Gynecol"},{"key":"R19-9-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"R20-9-20210131","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.","volume":"339","author":"Van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"R21-9-20210131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives wit 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study.","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"R23-9-20210131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2307\/2134847","article-title":"Mortality associated with fertility and fertility control: 1983.","volume":"15","author":"Ory","year":"1983","journal-title":"Family Planning Perspectives"},{"key":"R27-9-20210131","first-page":"585","article-title":"Contraceptive mechanism of microdose norethindrone.","volume":"41","author":"Moghissi","year":"1973","journal-title":"Obstet Gynecol"},{"key":"R28-9-20210131","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0015-0282(16)39255-X","article-title":"Morphological changes in the ovaries of women treated with continuous microdose progestogens.","volume":"23","author":"Moghissi","year":"1972","journal-title":"Fertil Steril"},{"key":"R29-9-20210131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.clpt.6100040","article-title":"ACTG A5093 Protocol Team. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.","volume":"81","author":"Cohn","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R30-9-20210131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2007.10.002","article-title":"Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.","volume":"77","author":"Watts","year":"2008","journal-title":"Contraception"},{"key":"R31-9-20210131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9378(75)90061-7","article-title":"Comparative studies of the ethinyl estrogens used in oral contraceptives. II. Antiovulatory potency.","volume":"122","author":"Goldzieher","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"R32-9-20210131","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.ftd.0000211825.57984.41","article-title":"An update on therapeutic drug monitoring for antiretroviral drugs.","volume":"28","author":"Back","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R33-9-20210131","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00042560-200108010-00004","article-title":"Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals.","volume":"27","author":"Veldkamp","year":"2001","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3181eb5ff5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:07Z","timestamp":1786041427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201012010-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181eb5ff5","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}